WednesdayNov 30, 2016 3:56 pm

Monaker Group, Inc. (MKGI) Building Innovative Travel Products for Work and Play

For six decades, Monaker Group (OTCQB: MKGI) has catered to leisure travelers seeking to book “vacations of a lifetime” or find “travel made easy” options. Along the way, the company has gained the knowledge and experience to be considered an industry-leading, technology-driven travel company. Now, equipped with decades of experience and leveraging over 60 years of operation in leisure travel, Monaker is expanding its reach to business travel, using the full resources of its multiple brands and divisions to offer novel travel products to executives and professionals traveling for work. Over the years, management has combined vital partnerships and established…

Continue Reading

WednesdayNov 30, 2016 3:15 pm

eXp World Holdings, Inc. (EXPI) Welcomes Marsee Wilhems Team to eXp Realty

Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced that the Tucson-based Marsee Wilhems Team, one of the premier real estate teams in the country, has joined the Agent-Owned Cloud Brokerage®. The addition continues on eXp Realty’s recent trend of attracting top real estate professionals from across the country to its ranks. Within the last six weeks alone, the company has welcomed the Brent Gove Team, one of the top real estate teams in California; Darren James Real Estate Experts, which was ranked 51st in the nation by The Wall Street Journal in 2015; and the Eric Burch Real Estate…

Continue Reading

WednesdayNov 30, 2016 1:08 pm

Recro Pharma, Inc. (REPH) Says No to Opioids for Post-Operative Pain Control with IV Meloxicam

An announcement earlier this week from revenue-generating specialty pharmaceutical company Recro Pharma, Inc. (NASDAQ: REPH) is good news for those suffering from pain after major surgery. From its headquarters in Malvern, Pennsylvania, the company announced positive results from a phase III clinical trial evaluating intravenous (IV) Meloxicam for the treatment of acute post-operative pain. In this trial, the second of two phase III trials, IV Meloxicam achieved the primary endpoint of a statistically significant differential in Summed Pain Intensity Difference over the first 24 hours (SPID-24) in patients who had undergone abdominoplasty surgery, as compared to placebo. With the positive…

Continue Reading

WednesdayNov 30, 2016 11:32 am

GCard from GainClients, Inc. (GCLT) Helps Real Estate Professionals Connect with Customers

As the entire real estate industry is changing fast, with the advent of technology and enhanced interconnectivity set to significantly alter the sector’s business customs, GainClients, Inc. (OTC: GCLT) is staying ahead of the curve with its GCard networking system (http://nnw.fm/R5Pkp), which is designed to help real estate professionals better connect and communicate with their customers. With a growing number of real estate customers opting for online and mobile real estate solutions, GCard is a progressive integrated networking system that allows real estate brokers and agents to provide their customers with a wealth of information, including property details, lending requirements,…

Continue Reading

WednesdayNov 30, 2016 9:16 am

Net Element, Inc. (NETE) Aims for the Millennial Generation and Beyond

Millennials, or ‘digital natives’, make up the generation of consumers on which many industries have focused their efforts for the past five to 10 years. According to the U.S. Census Bureau (http://nnw.fm/Xz26t), millennials are generally 18 to 35 years old and, with over 75 million members, represent the largest generation group. As a generation, they have a huge impact on the technology of our world, as they are the first generation to have always known the Internet. The millennial generation plays a critical role in leading the adoption of consumer technologies. This is one of the key reasons that professionals…

Continue Reading

TuesdayNov 29, 2016 4:00 pm

Moxian, Inc. (MOXC) Rings Nasdaq Trade Opening Bell to Celebrate Uplisting

After a long journey in which no efforts were spared, China’s online-to-offline integrated social media operator, Moxian, Inc. (NASDAQ: MOXC), was officially uplisted earlier this month when its common stock began trading on the Nasdaq Capital Market. To mark this moment, the company’s management traveled to New York City to ring the Nasdaq Trade opening bell last Wednesday, on November 23. The event at the Nasdaq MarketSite in Times Square was attended by CEO and Chairman James Tan and Executive Director Hao Qing Hu. The pair rang the trade opening bell at 9:30 a.m. ET to mark the beginning of…

Continue Reading

TuesdayNov 29, 2016 3:34 pm

eXp World Holdings, Inc. (EXPI) Keeping Up-To-Date with Buyer Demographics

According to The National Association of Realtors (http://nnw.fm/4IfCb), this October was the second month in a row to show incredible sales peaks in existing home sales, registering the highest sales rate in nearly 10 years. With existing home sales skyrocketing for yet another month, it is no surprise that real estate agencies are looking for ways to maintain a competitive edge, anxious to better serve their customers based upon preferences and demographics. eXp World Holdings, Inc. (OTCQB: EXPI), the holding company for eXp Realty LLC, a unique agent-owned cloud brokerage, believes in just this. In order to maintain a competitive…

Continue Reading

TuesdayNov 29, 2016 1:49 pm

Axsome Therapeutics, Inc. (AXSM) Shedding New Light on Old Drugs

New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) is tending to a major and thriving market where current treatment options are insufficient. This young company (founded in 2012) is striving to establish a fully-integrated biopharmaceutical business that will develop and bring to the healthcare marketplace therapies for the management and treatment of central nervous system (CNS) disorders. Axsome Therapeutics has a laser-like focus on differentiated therapies, in particular. To improve the lives of patients living with pain and various CNS disorders, Axsome has set its sights on working with both internally-derived drug candidates and in-licensed drug candidates in order to create…

Continue Reading

TuesdayNov 29, 2016 12:45 pm

Monaker Group (MKGI) Tapping into Fast-Growing $200 Billion Millennial Travel Market

The travel industry is growing exponentially, but must also be ready to become more flexible and make more changes to cater to the needs and requirements of the market segment currently driving its growth – the Millennials. This new generation of travelers has hit an average annual spending of $200 billion on tourism and travel, according to a FutureCast report titled ‘Millennial Brief on Travel & Lodging’ (http://nnw.fm/8uCmY). The figure is the largest average the tourism industry has ever seen, a trend that’s likely to be maintained, provided that the industry’s operators are able to meet the needs of this…

Continue Reading

TuesdayNov 29, 2016 11:28 am

OurPet’s Company (OPCO) is Growing Organically

At last month’s MicroCap Conference in Philadelphia, the technological prowess of OurPet’s Company (OTCQX: OPCO) was on display. A presentation (http://nnw.fm/y7mQ3) by the company’s chief financial officer, Scott Mendes, showed the many innovative products for cats and dogs, who are the rainmakers of OurPet’s Company. The CFO also gave an account of OPCO’s history of growth, from its genesis in 1985 as Napro, Inc. to the present. The company has grown both organically and through acquisitions. CEO Dr. Steve Tsengas wants to double its size and, to support that expansion, has invested heavily in distribution and marketing infrastructure. The company…

Continue Reading

Contact us: 212.418.1217